TMDX
TMDX
US89377M1099
TransMedics Group, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
2.69B EUR
2.3B EUR
3.43B EUR
4.17B EUR
Enterprise Value
3.13B EUR
2.7B EUR
3.84B EUR
4.2B EUR
Valuation Multiples
Trailing P/E
20.17x
15.16x
19.98x
25.32x
Forward P/E
34.55x
--
--
--
Price to Sales
4.03x
3.44x
5.4x
9.02x
Price to Book
5.21x
4.44x
6.95x
8.81x
EV/Revenue
4.69x
4.03x
6.03x
9.09x
EV/EBITDA
27.11x
20.7x
27.59x
37.66x
Price to FCF (P/FCF)
60.48x
29.1x
22.69x
25.5x
EV/FCF
70.44x
34.1x
25.34x
25.69x
FCF Yield
1.65%
3.44%
4.41%
3.92%
ende